Obstetric uses of intravenous immunoglobulin: Successes, failures, and promises

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 4, 2001, Pages S133-S138

  Branch, D Ware ^a   Porter, T Flint ^a   Belfort, Michael A ^a   Paidas, Michael J ^b   Gonik, Bernard ^c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antiphospholipid syndrome; Fetal neonatal alloimmune hemolysis; Fetal neonatal alloimmune thrombocytopenia; Intravenous immune globulin; Recurrent pregnancy loss

Indexed keywords

ACETYLSALICYLIC ACID; ERYTHROCYTE ANTIBODY; HEPARIN; IMMUNOGLOBULIN;

ALLOIMMUNITY; ANTIPHOSPHOLIPID SYNDROME; AUTOIMMUNE DISEASE; CONFERENCE PAPER; DRUG EFFICACY; HEMOLYSIS; HUMAN; IMMUNE DEFICIENCY; OBSTETRICS; PRIORITY JOURNAL; RECURRENT ABORTION; THROMBOCYTOPENIA; TREATMENT FAILURE; TREATMENT INDICATION;

ABORTION, HABITUAL; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FETAL DISEASES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PREGNANCY; PREGNANCY COMPLICATIONS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 0034769722     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.117821     Document Type: Article

References (50)

1. 347 Cases of fetal alloimmune thrombocytopenia
2. Alloimmunization to the PLA1 platelet antigen: Results of a prospective study
3. Fetal alloimmune thrombocytopenia
4. Feto-maternal alloimmune thrombocytopenia: Antenatal therapy with IvIgG and steroids-More questions than answers. European Working Group on Feto-maternal Alloimmune Thrombocytopenia
5. Neonatal alloimmune thrombocytopenia (NAIT): A prospective case accumulation study
6. Antenatal management of alloimmune thrombocytopenia with intravenous immune globulin: A randomized trial of the addition of low-dose steroid to intravenous immune globulin
7. Fetal alloimmune thrombocytopenia: Consensus and controversy
8. Antenatal management of fetomaternal alloimmune thrombocytopenia-Report of 15 affected pregnancies
9. Neonatal alloimmune thrombocytopenia: Antenatal management
10. Thrombocytopenia in pregnancy
11. New approaches in the treatment of hemolytic disease of the fetus
12. Prevention of Rh D alloimmunization
13. Intravenous gamma globulin in pregnancy: A review
14. Alloimmunization during pregnancy treated with high dose intravenous immunoglobulin. Effects on fetal hemoglobin concentration and anti-D concentrations in the mother and fetus
15. Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin
16. Intravenous gamma globulin to prevent stillbirth in rhesus incompatibility
17. High dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization
18. High-dose intravenous gamma globulin: Does it have a role in the treatment of severe erythroblastosis fetalis
19. Intravenous immunoglobulin treatment of pregnant patients with recurrent pregnancy loss caused by antiphospholipid antibodies and Rh immunization
20. Intravenous immune globulin in the management of severe Rh D hemolytic disease
21. High-dose intravenous IgG for the treatment of severe Rhesus alloimmunization
22. High dose gamma globulin followed by intrauterine transfusions: A new alternative for the treatment of severe fetal hemolytic disease
23. No beneficial effect of low-dose fetal intravenous gamma globulin administration in combination with intravascular transfusions in severe Rh D hemolytic disease
24. Immunoglobulin administration to fetuses with anemia due to alloimmunization to D
25. Manipulating the immune system with immunoglobulin
26. Intravenous immunoglobulin inhibits natural killer cell activity in vivo in women with recurrent spontaneous abortion
27. Elevated peripheral blood natural killer cells are effectively down-regulated by immunoglobulin G infusion in women with recurrent spontaneous abortions
28. Natural killer (NK) cell subsets and NK cell cytotoxicity in women with histories of recurrent spontaneous abortions
29. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin
30. IVIG to prevent recurrent spontaneous abortion
31. Intravenous immunoglobulin for the treatment of recurrent pregnancy loss
32. Intravenous immunoglobulin in the prevention of recurrent miscarriage
33. Placebo-controlled trial for treatment of unexplained secondary recurrent abortions and recurrent late spontaneous abortions with IV immunoglobulin
34. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: A prospective, randomized, double-blinded, placebo-controlled trial
35. Short-term therapy for recurrent abortion using intravenous immunoglobulins: Results of a double-blind placebo-controlled Italian study
36. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: A double-blind placebo-controlled study
37. Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage
38. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop
39. Which are the best biological markers of the antiphospholipid syndrome?
40. Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: A model for autoimmune fetal loss
41. Induction of antiphospholipid syndrome in naive mice with mouse lupus monoclonal and human polyclonal anticardiolipin antibodies
42. Experimental thrombosis and antiphospholipid antibodies: New insights
43. Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience
44. A study of 60 pregnancies in patients with the antiphospholipid syndrome
45. Antiphospholipid antibody-associated recurrent pregnancy loss: Treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone
46. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies
47. Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial
48. Pregnancy complicated by the antiphospholipid syndrome: Outcomes with intravenous immunoglobulin therapy
49. Intravenous immunoglobulin therapy for the antiphospholipid syndrome in pregnancy
50. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy